Immunoglobulin G1 [351-alanine,386-alanine,387-alanine] anti-(human epidermal growth factor receptor HER2) (human-Mus musculus monoclonal IMM2902 ?1-chain), disulfide with 1-125-signal regulatory protein ? [80-alanine] (human isoform 4 variant) fusion protein with peptide linker ((GGGGS)3) fusion protein with human-Mus musculus monoclonal IMM2902 ?-chain, dimer
Advanced Cholangiocarcinoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.monoclonal_antibodyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
92 Active assets in the Advanced Cholangiocarcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUOROURACILUM Jonsson Comprehensive Cancer Center | Phase 3 | BB |
Eloxatin Jonsson Comprehensive Cancer Center | Phase 3 | BB |
Irinotecan Jonsson Comprehensive Cancer Center | Phase 3 | B |
ETOMIDATE Cheju Halla General Hospital | Phase 4 | B |
Docetaxel Merck Sharp & Dohme LLC | Phase 2 | B |
View all 50 →
Same molecule, other indications
Immunoglobulin G1 [351-alanine,386-alanine,387-alanine] anti-(human epidermal growth factor receptor HER2) (human-Mus musculus monoclonal IMM2902 ?1-chain), disulfide with 1-125-signal regulatory protein ? [80-alanine] (human isoform 4 variant) fusion protein with peptide linker ((GGGGS)3) fusion protein with human-Mus musculus monoclonal IMM2902 ?-chain, dimer is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →